Research Article
[Retracted] Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy
Table 1
Patient baseline characteristics.
| | Characteristic | Roxadustat () | Control () | value |
| | Age (years) | | | 0.590 | | Male sex, (%) | 14 (46.7%) | 16(53.3%) | 0.606 | | Weight (kg) | | | 0.431 | | Diabetics, (%) | 8 (26.7%) | 9 (30%) | 0.774 | | Hypertensives, (%) | 21 (70%) | 23 (76.7%) | 0.559 | | Iron users, (%) | 19 (63.3%) | 24 (56.7%) | 0.152 | | TC (mmol/L) | | | 0.498 | | Albumin (g/L) | | | 0.468 | | TG (mmol/L) | | | 0.664 | | LDL-C (mmol/L) | | | 0.472 | | HDL-C (mmol/L) | | | 0.178 | | Leukocytes (×109/L) | | | 0.481 | | Fasting glucose (mmol/L) | | | 0.336 | | eGFR (ml/L) | | | 0.755 | | BUN(mmol/L) | | | 0.351 |
|
|
